Therefore, more aggressive treatment, such as adjuvant chemotherapy or radiotherapy, and short-term follow-up should be considered in advanced-stage HCC patients with LC3 expression after hepatic resection. This evidence concerns the gene MAP1LC3A and hepatocellular carcinoma.